Qutenza Medicated Topical Patch 8pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Qutenza: Medicated topical patch (8%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

CAPSAICIN (cap SAY sin) is a pain reliever. It is used to treat postherpetic neuralgia (PHN) pain.

In-Depth Information
Select a Medication

Qutenza 8% Topical Patch Kit

NDC: 101440928
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Postherpetic Neuralgia, Neuropathic Pain

Storage Information
Store in original package until time of use
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Qutenza 8% Topical Patch Kit

Reported Side Effects for Qutenza 8% Topical Patch Kit

Throat Irritation Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Burns Incidence:
<0.5%*
Severity: MODERATE
Onset: EARLY
Dry Skin Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
2.0-6.0%*
Severity: MILD
Onset: RAPID
High Blood Pressure Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Vomiting Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
63.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Qutenza

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5